Skip to content

LLY

Eli Lilly and Company

Research and development, 2025
$13.3B
YoY, 2025
+21.3%
5-year CAGR
+17.4%
10-year CAGR
+10.8%

Research and development

Research and development by fiscal year

PeriodR&DYoY
2025$13.3B+21.3%
2024$11.0B+18.0%
2023$9.3B+29.5%
2022$7.2B+3.8%
2021$6.9B+16.0%
2020$6.0B+6.8%
2019$5.6B+10.8%
2018$5.1B−0.9%
2017$5.1B−4.0%
2016$5.3B+10.7%
2015$4.8B+1.3%
2014$4.7B−14.4%
2013$5.5B+4.8%
2012$5.3B+5.1%
2011$5.0B+2.8%
2010$4.9B+12.9%
2009$4.3B+12.6%
2008$3.8B+10.2%
2007$3.5B—